Discover critical updates from Conduit Pharmaceuticals Inc. in its 8-K filing. Get insights on common stock, redeemable warrants, and financial implications as of February 12, 2025.
Explore Conduit Pharmaceuticals Inc.'s 8-K filing from February 7, 2025, detailing common stock, redeemable warrants, and trading symbols CDT and CDTTW on NASDAQ.
Explore Conduit Pharmaceuticals Inc.'s latest 8-K report from January 13, 2025, detailing stock, warrants, and financial strategies. Essential for investors and analysts.
Explore Conduit Pharmaceuticals Inc.'s 8-K report from December 12, 2024, detailing stock performance, financial metrics, and essential updates for investors and stakeholders.